Bigul

Rainbow Children's Medicare Ltd - 543524 - Appointment Of Chief Financial Officer Of The Company

With reference to the captioned subject, please take note that upon recommendation of the Nomination and Remuneration Committee and the Audit Committee, the Board of Directors in their meeting held today i.e., May 31, 2023, approved appointment of Mr. Vikas Maheshwari as the Chief Financial Officer (Key Managerial Personnel) of the Company with effect from June 1, 2023.
31-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

With reference to the captioned subject, please take note that Mr. R Gowrisankar, has resigned from the post of Chief Financial Officer (Key Managerial Personnel) of the Company due to personal reasons effective from May 31, 2023 (close of business hours). Mr. Gowrisankar shall now be serving his notice period and his last working day in the Company will be June 30, 2023.
31-05-2023

Tata Technologies plans to hire 1,000 women engineers to promote diversity

Global engineering and product development digital services firm Tata Technologies Ltd on Tuesday said it aims to hire over 1,000 women engineers in 2023-24 as part of its move to promote gender diversity across its workforce. The company has launched its gender diversity-focused hiring campaign while encouraging women to join it for engineering a better world, Tata Technologies said in a statement. Through its 'RAINBOW' programme, the company said it has focused interventions on onboarding more women and parallelly creating support frameworks for them to succeed. Under it, there will be focused efforts towards attracting and onboarding diverse talent pool, it said adding, "The company aims to hire 1000 (plus) women engineers in FY24, to strengthen its gender diversity ratio further and has identified specific opportunities for women.. It will also focus on career growth by "grooming women leaders for tomorrow through the LeaderBridge-WINGS program, a six-month developmental...
30-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find enclosed herewith the Annual Secretarial Compliance Report issued by M/s. Ravi & Subramanyam Company Secretaries, for the Financial Year ended March 31, 2023.
24-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the Transcript of the Investor call held on May 15, 2023, with regard to Financial Results of the Company for Q4 & FY23.
22-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 30 and 47 of the Listing Regulations, please find attached copies of newspaper advertisement of Financial Results of the Company for the Quarter and Financial Year ended on March 31, 2023, published in Business Standard and Surya on May 16, 2023.
16-05-2023
Bigul

Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30 and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the audio recording of the Company's Conference Call dated May 15, 2023 with the Investors/ Analysts for Q4 & FY23 is available on the Company''s website at: https://www.rainbowhospitals.in/investor-relations/reports/RCML-Q4-and-FY23-Earnings-Audio.mp3
15-05-2023

Rainbow Childrens Medicare Results Earnings Call for Q4FY23

Conference Call with Rainbow Childrens Medicare Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
15-05-2023
Bigul

Q4FY23 Quarterly & FY23 Annual Result Announced for Rainbow Children's Medicare Ltd.

Healthcare Facilities company Rainbow Children's Medicare announced Q4FY23 & FY23 results: Q4FY23 vs Q4FY22: Revenue: Rs 3,169.66 million vs Rs 2,124.47 million, up 49.20% YoY EBITDA: Rs 980.07 million vs Rs 481.33 million, up 103.62% YoY EBITDA %: 30.92% vs 22.66%, up 826 bps YoY PAT: Rs 538.63 million vs Rs 122.60 million, up 339.34% YoY PAT %: 16.99% vs 5.77%, up 1,122 bps YoY FY23 vs FY22: Revenue: Rs 11,735.74 million vs Rs 9,737.58 million, up 20.52% YoY EBITDA: Rs 3,963.77 million vs Rs 3,048.75 million, up 30.01% YoY EBITDA %: 33.78% vs 31.31%, up 247 bps YoY PAT: Rs 2,123.77 million vs Rs 1,386.73 million, up 53.15% YoY PAT %: 18.10% vs 14.24%, up 386 bps YoY Commenting on the performance for Q4FY23, Dr. Ramesh Kancharla, Chairman & Managing Director, Rainbow Children’s Medicare (RCML), said, “I am pleased to inform you that the company has delivered robust quarterly performance, led by high patient footfall across hospitals. The revenues for Q4FY23 were Rs 3,169.66 million, which is a growth of 49.20% compared to Rs 2,124.47 million in Q4FY22. The EBIDTA for Q4FY23 was Rs 980.07 million, which is a growth of 103.62% compared to Rs 481.33 million in Q4FY22, and the PAT for Q4FY23 was Rs 538.63 million, which is a growth of 339.34% compared to Rs 122.60 million in Q4FY22. The company is focused on executing the business plan, put forth during the IPO, of adding 1000 beds across the target markets. The proposed expansion for the current financial year includes the addition of ~270 beds in Central Hyderabad (60 beds), Hydernagar (50 beds), Anna Nagar (80 beds), and Sarjapur (80 beds). Additional ~160 beds are slated for commencement in the next financial year at Rajahmundry (100 beds) and a new spoke hospital in Bengaluru (60 beds). Furthermore, the company aims to increase its bed count by ~400 across the National Capital Region by FY26-27. The company remains committed to fulfilling its mission of delivering excellent multi-disciplinary pediatric and perinatal care and strives to enhance its service offerings by making constant improvements.” Result PDF
15-05-2023
Next Page
Close

Let's Open Free Demat Account